chr16-8859252-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014316.4(CARHSP1):c.77G>A(p.Ser26Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,601,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CARHSP1 | NM_014316.4 | c.77G>A | p.Ser26Asn | missense_variant | 2/4 | ENST00000311052.10 | |
LOC100130283 | NR_147908.1 | n.635-876C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CARHSP1 | ENST00000311052.10 | c.77G>A | p.Ser26Asn | missense_variant | 2/4 | 1 | NM_014316.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000212 AC: 3AN: 141298Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000285 AC: 7AN: 245330Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133570
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459808Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 726194
GnomAD4 genome AF: 0.0000212 AC: 3AN: 141298Hom.: 0 Cov.: 26 AF XY: 0.0000295 AC XY: 2AN XY: 67710
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.77G>A (p.S26N) alteration is located in exon 2 (coding exon 1) of the CARHSP1 gene. This alteration results from a G to A substitution at nucleotide position 77, causing the serine (S) at amino acid position 26 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at